duloxetine hydrochloride has been researched along with atomoxetine hydrochloride in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bercu, JP; Fiori, JM; Meyerhoff, RD; Parke, NJ | 1 |
| Attali, P; Bienaymé, H; Ferté, J; Lluel, P; Ocaña, AV; Palea, S; Pérez-Martínez, FC; Rekik, M; Vela-Navarrete, R; Virseda, J | 1 |
| Kielbasa, W; Stratford, RE | 1 |
| Martin, WJ; Obedencio, GP; Shen, F; Smith, JA; Tsuruda, PR | 1 |
| Buchwald, SL; Shi, SL | 1 |
| Hu, Q; Imamoto, T; Liu, Y; Zhang, W; Zhang, Z | 1 |
| Kielbasa, W; Lobo, E | 1 |
| Aghamohammadhasan, M; Chamsaz, M; Ghorbani, M; Shams, A | 1 |
| Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
| Alamiri, B; Naguy, A | 1 |
11 other study(ies) available for duloxetine hydrochloride and atomoxetine hydrochloride
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human health risk assessments for three neuropharmaceutical compounds in surface waters.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Benzodiazepines; Drug Residues; Duloxetine Hydrochloride; Environmental Exposure; Fishes; Food Analysis; Forecasting; Humans; Models, Statistical; No-Observed-Adverse-Effect Level; Olanzapine; Propylamines; Risk Assessment; Thiophenes; United States; Water Pollutants, Chemical; Water Supply | 2008 |
Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function.
Topics: Anesthesia; Anesthetics; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Electromyography; Female; Halothane; Humans; Indoles; Muscle, Smooth; Norepinephrine; Prazosin; Propylamines; Pyridines; Rabbits; Retrospective Studies; Thiophenes; Urinary Tract; Urinary Tract Infections; Urodynamics | 2011 |
Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses.
Topics: Animals; Atomoxetine Hydrochloride; Biomarkers; Brain; Clinical Medicine; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Duloxetine Hydrochloride; Extracellular Fluid; Humans; Male; Microdialysis; Models, Biological; Predictive Value of Tests; Propylamines; Rats; Rats, Sprague-Dawley; Species Specificity; Thiophenes | 2012 |
Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.
Topics: Analgesia; Animals; Atomoxetine Hydrochloride; Biogenic Monoamines; Chromatography, Liquid; Drug Synergism; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Morphine; Morpholines; Neurotransmitter Uptake Inhibitors; Nociceptive Pain; Norepinephrine Plasma Membrane Transport Proteins; Ondansetron; Propylamines; Rats; Rotarod Performance Test; Serotonin Plasma Membrane Transport Proteins; Tandem Mass Spectrometry; Thiophenes | 2013 |
Copper-catalysed selective hydroamination reactions of alkynes.
Topics: Alkynes; Amination; Amines; Atomoxetine Hydrochloride; Benzhydryl Compounds; Catalysis; Copper; Cresols; Duloxetine Hydrochloride; Fluoxetine; Phenylpropanolamine; Propylamines; Stereoisomerism; Thiophenes; Tolterodine Tartrate | 2015 |
ZnCl2 -promoted asymmetric hydrogenation of β-secondary-amino ketones catalyzed by a P-chiral Rh-bisphosphine complex.
Topics: Amination; Amino Alcohols; Atomoxetine Hydrochloride; Catalysis; Chlorides; Coordination Complexes; Duloxetine Hydrochloride; Fluoxetine; Hydrogenation; Ketones; Phosphines; Propylamines; Rhodium; Stereoisomerism; Thiophenes; Zinc Compounds | 2015 |
Pharmacodynamics of norepinephrine reuptake inhibition: Modeling the peripheral and central effects of atomoxetine, duloxetine, and edivoxetine on the biomarker 3,4-dihydroxyphenylglycol in humans.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Atomoxetine Hydrochloride; Biomarkers; Clinical Trials as Topic; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Models, Biological; Morpholines; Norepinephrine; Phenylethyl Alcohol; Young Adult | 2015 |
Ultrasonic assisted magnetic dispersive solid phase microextraction for pre concentration of serotonin-norepinephrine reuptake inhibitor drugs.
Topics: Atomoxetine Hydrochloride; Duloxetine Hydrochloride; Graphite; Humans; Limit of Detection; Magnetics; Microscopy, Electron, Scanning; Nanocomposites; Quantum Dots; Rivers; Serotonin and Noradrenaline Reuptake Inhibitors; Solid Phase Microextraction; Ultrasonics; Venlafaxine Hydrochloride; Water Pollutants, Chemical; Water Supply; Water Wells | 2018 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Takotsubo Cardiomyopathy Related to Duloxetine-Atomoxetine Combination in an Adolescent with ADHD and Comorbid GAD.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Comorbidity; Duloxetine Hydrochloride; Humans; Takotsubo Cardiomyopathy | 2023 |